This Director Services Agreement is made this 18th day of April 2011. Between:Director Services Agreement • May 10th, 2011 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2011 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Hong Kong
Secondment ContractSecondment Contract • May 10th, 2011 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
ANNEXURE 1 - CHANGE IN CONTROL AGREEMENTChange in Control Agreement • May 10th, 2011 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Hong Kong
This Change in Control Agreement (“Agreement”) is effective as of April 18, 2011, by and between Mr. Mark Lotter (“Employee”) and SciClone Pharmaceuticals Hong Kong Limited (the “Company”).
SHARE PURCHASE AGREEMENTShare Purchase Agreement • May 10th, 2011 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS SHARE PURCHASE AGREEMENT (this “Agreement”) dated as of April 18, 2011 is by and among SciClone Pharmaceuticals, Inc., a Delaware corporation (“Parent”), SciClone Pharmaceuticals Hong Kong Limited, a company incorporated and existing under the laws of Hong Kong and wholly-owned subsidiary of Parent (“Purchaser”), NovaMed Pharmaceuticals, Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Target”), and the undersigned individuals as set forth on the signature pages hereto (each a “Seller” and collectively, the “Sellers”), and, with respect to Sections 2, 7, 9, 10 and 11, Mark Lotter as the Seller Representative.
